Wisconsin bills · 2025-2026 Regular Session
Wisconsin SB 1149
Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Spreitzer (Democratic)
- Smith (Democratic)
- Roys (Democratic)
- Ratcliff (Democratic)
- Larson (Democratic)
- Hesselbein (Democratic)
- Dassler-Alfheim (Democratic)
- Carpenter (Democratic)
- Pfaff (Democratic)
Summary
No official summary is available for this bill.
Latest action(Mar 23, 2026): Failed to pass pursuant to Senate Joint Resolution 1
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 23, 2026 · Senate
Failed to pass pursuant to Senate Joint Resolution 1 - Mar 19, 2026 · Senate
Read first time and referred to Committee on Health - Mar 19, 2026 · Senate
Introduced by Senators Pfaff, Carpenter, Dassler-Alfheim, Hesselbein, Larson, Ratcliff, Roys, Smith and Spreitzer; cosponsored by Representatives Roe, Subeck, Bare, Brown, Clancy, DeSanto, Emerson, Goodwin, Hong, Joers, Kirsch, Miresse, Moore Omokunde, Sinicki, Snodgrass, Tenorio, Udell, Vining and Anderson